Research Impact

h-index

N/A

Research impact score

Publications

0

Total publications

Trial Results

0

Published trial results

Citations

0

Total citations

Drug Portfolio

Analytics

Trial Phases

Phase 11
Phase 22

Trial Status

Terminated2
Other1

Role Distribution

Principal Investigator3
PI Rate100%

Activity Timeline

Clinical Trials (3)

NCT04216472Phase 2Terminated
Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterations
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+19 more
PrincipalinvestigatorStart date: 2020-07-10
NCT03579472Phase 1Terminated
M7824 and Eribulin Mesylate in Treating Patients With Metastatic Triple Negative Breast Cancer
Anatomic Stage IV Breast Cancer AJCC v8Metastatic Triple-Negative Breast CarcinomaPrognostic Stage IV Breast Cancer AJCC v8
PrincipalinvestigatorStart date: 2018-05-30
NCT01334021Phase 2Active Not Recruiting
Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer
Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+20 more
PrincipalinvestigatorStart date: 2011-05-31

Research Network

Collaboration Network

1 collaborators·0 connections
Network Legend
KOL
Current Investigator
CO
High-influence Collaborator
CO
Collaborator
Click: view details
Double-click: go to profile
Drag: move node

Similar Key Opinion Leaders

Discover other key opinion leaders with similar research profiles, therapeutic areas, and collaboration networks.

10 similar investigators found

Heather Greenlee

Fred Hutch/University of Washington Cancer Consortium

Related
5 trials

Shared therapeutic areas:

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+17 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score23%

Lorenzo Cohen

M.D. Anderson Cancer Center

Related
10 trials

Shared therapeutic areas:

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+17 more

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score23%

Timothy A Yap

M.D. Anderson Cancer Center

Related
4 trials

Shared therapeutic areas:

Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IIIA Breast Cancer AJCC v8Anatomic Stage IIIB Breast Cancer AJCC v8+8 more

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score13%

Carlos E. Vargas, M.D.

Mayo Clinic

Related
5 trials

Shared therapeutic areas:

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+7 more
Similarity Score12%

Banu Arun

M.D. Anderson Cancer Center

Related
5 trials

Shared therapeutic areas:

Anatomic Stage IV Breast Cancer AJCC v8Prognostic Stage IV Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+7 more

Worked with same sponsors:

M.D. Anderson Cancer CenterNational Cancer Institute (NCI)
Similarity Score12%

Joanne Mortimer

City of Hope Medical Center

Related
8 trials

Shared therapeutic areas:

Anatomic Stage IV Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8Metastatic Triple-Negative Breast Carcinoma+1 more

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score5%

Saranya Chumsri, MD

Mayo Clinic

Related
5 trials

Shared therapeutic areas:

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8+1 more
Similarity Score5%

Anand Dhruva, MD

University of California, San Francisco

Related
6 trials

Shared therapeutic areas:

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8
Similarity Score3%

Glenn Lesser, MD

Wake Forest University Health Sciences

Related
10 trials

Shared therapeutic areas:

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage II Breast Cancer AJCC v8Anatomic Stage III Breast Cancer AJCC v8

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Matthew P. Goetz, M.D.

Mayo Clinic

Related
4 trials

Shared therapeutic areas:

Anatomic Stage III Breast Cancer AJCC v8Anatomic Stage IV Breast Cancer AJCC v8Metastatic Triple-Negative Breast Carcinoma

Worked with same sponsors:

National Cancer Institute (NCI)
Similarity Score3%

Publications (0)

No publications found for this investigator.

Clinical Trials (3)

Showing 3 of 3 trials

NCT04216472Phase 2PrincipalInvestigator

Nab-paclitaxel and Alpelisib for the Treatment of Anthracycline Refractory Triple Negative Breast Cancer With PIK3CA or PTEN Alterations

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+19 more
Terminated
NCT03579472Phase 1PrincipalInvestigator

M7824 and Eribulin Mesylate in Treating Patients With Metastatic Triple Negative Breast Cancer

Anatomic Stage IV Breast Cancer AJCC v8Metastatic Triple-Negative Breast CarcinomaPrognostic Stage IV Breast Cancer AJCC v8
Terminated
NCT01334021Phase 2PrincipalInvestigator

Genetic Testing in Predicting Tumor Response in Patients With Stage I-III HER2 Negative Invasive Breast Cancer

Anatomic Stage I Breast Cancer AJCC v8Anatomic Stage IA Breast Cancer AJCC v8Anatomic Stage IB Breast Cancer AJCC v8+20 more
Active Not Recruiting

All 3 trials loaded